SG Americas Securities LLC Boosts Stake in Oscar Health, Inc. $OSCR

SG Americas Securities LLC grew its position in shares of Oscar Health, Inc. (NYSE:OSCR) by 886.8% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 921,288 shares of the company’s stock after buying an additional 827,929 shares during the quarter. SG Americas Securities LLC’s holdings in Oscar Health were worth $13,239,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Farther Finance Advisors LLC grew its holdings in shares of Oscar Health by 4,420.7% in the third quarter. Farther Finance Advisors LLC now owns 1,311 shares of the company’s stock valued at $25,000 after acquiring an additional 1,282 shares in the last quarter. Quarry LP lifted its holdings in Oscar Health by 439.8% during the third quarter. Quarry LP now owns 1,803 shares of the company’s stock worth $34,000 after acquiring an additional 1,469 shares during the period. Tsfg LLC bought a new stake in Oscar Health during the third quarter worth $38,000. Jones Financial Companies Lllp boosted its position in Oscar Health by 7,473.3% in the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after purchasing an additional 2,242 shares during the last quarter. Finally, Strs Ohio purchased a new position in Oscar Health in the first quarter worth $30,000. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on OSCR shares. Barclays set a $18.00 target price on Oscar Health and gave the company an “equal weight” rating in a research report on Monday, January 5th. Wall Street Zen upgraded shares of Oscar Health from a “sell” rating to a “hold” rating in a research report on Saturday, February 14th. Weiss Ratings restated a “sell (d)” rating on shares of Oscar Health in a report on Thursday, January 22nd. Raymond James Financial raised shares of Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 price objective on the stock in a research report on Thursday, February 12th. Finally, Stephens assumed coverage on shares of Oscar Health in a research note on Thursday, December 11th. They issued an “equal weight” rating and a $17.00 target price on the stock. Two analysts have rated the stock with a Buy rating, six have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $16.88.

Oscar Health Stock Performance

Shares of OSCR opened at $11.16 on Friday. The firm has a market cap of $3.32 billion, a PE ratio of -6.41 and a beta of 1.91. The stock’s fifty day moving average price is $13.64 and its two-hundred day moving average price is $16.09. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.96 and a quick ratio of 0.96. Oscar Health, Inc. has a 1 year low of $11.05 and a 1 year high of $23.80.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Tuesday, February 10th. The company reported ($1.24) earnings per share for the quarter, missing the consensus estimate of ($0.92) by ($0.32). Oscar Health had a negative return on equity of 39.35% and a negative net margin of 3.79%.The firm had revenue of $2.81 billion for the quarter, compared to the consensus estimate of $3.12 billion. During the same quarter in the previous year, the company posted ($0.62) EPS. The firm’s revenue was up 17.3% compared to the same quarter last year. On average, equities research analysts forecast that Oscar Health, Inc. will post 0.69 EPS for the current year.

Insider Buying and Selling

In other Oscar Health news, insider Mario Schlosser sold 23,038 shares of the stock in a transaction dated Thursday, January 8th. The shares were sold at an average price of $17.65, for a total transaction of $406,620.70. Following the completion of the transaction, the insider owned 350,180 shares in the company, valued at $6,180,677. This trade represents a 6.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 24.39% of the stock is currently owned by company insiders.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.